Form 8-K



Washington, D.C. 20549




Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): February 28, 2007



(Exact name of registrant as specified in charter)



Delaware   0-27527   22-3672377
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

968 Albany-Shaker Road, Latham, New York 12110

(Address of Principal Executive Offices) (Zip Code)


(518) 782-7700

(Registrant’s telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):


  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.


(c) Appointment of Interim Chief Financial Officer

On February 28, 2007, the Board of Directors of the Company appointed David Waldek as the interim Chief Financial Officer.

Mr. Waldek joined the Company as a consultant on February 28, 2007. Prior to joining the Company, Mr. Waldek co-founded CFO Advisory Group which provides strategic financial and business advisory services to high-growth companies. Prior to that, Mr. Waldek served for six years as the CFO for Albany Molecular Research.

As the interim Chief Financial Officer, Mr. Waldek is currently engaged by the Company as a consultant. The Company pays $1,250 per day for Mr. Waldek’s services.

On February 28, 2007, the Company issued a press release regarding the appointment of Mr. Waldek. The press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.


Item 9.01 Financial Statements and Exhibits.


(d) Exhibits.


Exhibit Number   


99.1    Press Release of Plug Power Inc. dated February 28, 2007.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


            PLUG POWER INC.
Date: March 1, 2007     By:   /s/ Roger B. Saillant
      Roger B. Saillant
      Chief Executive Officer